Optalert in the News

Optalert today announced that vehicles fitted with its Johns Drowsiness Scale (JDS) algorithm are now rolling off production lines for a leading European OEM – marking the first time a clinically validated, false-alert-free driver monitoring system has entered mass automotive production.

International Mining explores the evolution of mining safety ecosystems, featuring Optalert’s Eagle Insights and evidence-based fatigue risk management.

The Owl Eye app was featured in the September issue of Santé Magazine, France’s largest health and lifestyle magazine. The translation is below: “Owl Eye is an app that analyses eyelid micro-movements while you look at the screen. It was developed by Dr. Murray Johns, creator of the Epworth Sleepiness Scale, which is widely used...

The Owl Eye app was featured in Prevention Magazine in their April 2025 issue, highlighting the app’s ability to help detect signs of sleep issues through blinking and eyelid movement.

The 7NEWS feature highlighted how we developed the Owl Eye app, the clinical research behind it, and how it’s paving the way for accessible sleep health technology for all Australians.

French television series Direct Auto interviewed automotive technical services provider UTAC, showcasing Optalert’s drowsiness detection system.

Ticker News interviewed Optalert CMO Paul Zubrinich about the Owl Eye app that detects signs of sleep issues in minutes.

Australian medical technology company Optalert has revealed a breakthrough test for sleep issues, expanding access to sleep health technologies for millions of Australians.

Optalert CMO Paul Zubrinich wrote this piece for end consumers to assess the main features in driver monitoring systems when buying a car.

It’s currently impossible to accurately determine the number of crashes, injuries, and fatalities caused by drowsy driving, but numbers increase yearly.